期刊文献+

来那度胺增强细胞因子诱导的杀伤细胞杀伤效应的研究 被引量:1

Lenalidomide enhances anti-tumor effects of CIK cells against lymphoma
原文传递
导出
摘要 目的探讨来那度胺调节细胞因子诱导的杀伤(CIK)细胞对淋巴瘤细胞的杀伤效应。方法取健康志愿者外周血单个核细胞,经过干扰素-γ(INF-γ)、白细胞介素-2(IL-2)、抗CD3单抗诱导CIK细胞增殖,并对培养不同时间CIK细胞用不同浓度来那度胺进行处理。流式细胞术检测CD;CD;6细胞比例;酶联免疫吸附(ELISA)法检测粒.巨噬细胞集落刺激因子(GM-CSF)、INF-γ及肿瘤坏死因子α(TNF—α)的分泌水平;用CellCountingKit-8(CCK-8)试剂盒检测来那度胺作用后的CIK细胞及未处理的CIK细胞对3种淋巴瘤细胞株的体外杀伤效应。结果CIK细胞在多种细胞因子诱导下,CD3 CD56细胞比例明显增加,0.2~5.0μmol/L的来那度胺对其扩增分化没有影响(P〉0.05)。来那度胺作用下CIK细胞分泌GM—CSF、INFμ、TNF-α水平有显著提高(P〈0.05)。在1.0μmol/L来那度胺作用下CIK细胞对淋巴瘤细胞的杀伤效力明显高于未经来那度胺处理的CIK细胞[(42.53±2.19)%比(15.5±3.82)%;(44.78±4.86)%比(29.94±6.33)%;(54.71±5.31)%比(37.43±9.75)%1。结论在来那度胺作用下,CIK细胞分泌功能和对3种淋巴瘤细胞的杀伤效应均有显著增强。 ObJective To investigate lenalidomide modulates anti-tumor effects of cytokine induced killer(CIK) cells against lymphoma cells in vitro. Methods CIK cells were generated in vitro by stimulation of health donors' peripheral blood mononuclear cells subsets with interferon-gamma(INF-γ), IL-2 and anti-CD3 monoelonal antibody. On the different culture time CIK cells were treated with different concentrations of lenalidomide. CD;CD;6 cell ratio was detected by flow cytometry and ELISA method was used for the detection of GM-CSF, INF-γ and TNF-α level of secretion. Inhibitory effects of CIK cells and CIK cells treated by lenalidomide on the three types of lymphoma cell lines were detected by cell counting kit-8(CCK-8). Results Amount of CD3CD56 cells were increased without inhibition by lenalidomide at 0.2-5.0μmol/L (P〉0.05). Lenalidomide led to significantly higher levels of GM-CSF, INF-γ and TNF-α secreted by CIK cells (P〈0.05) . On different culture time C1K cells treated by 1.0 μmol/L lenalidomide had higher killing effects on Z-138 [(42.53±2.19) % vs(15.5±3.82) %], Jurkat[(44.78±4.86) % vs(29.94±6.33) %], RPMI 8226 cells [(54.71± 5.31) % vs(37.43±9.75) %]than that without lenalidomide treating(P〈0.05).Conelusion Lenalidomide can enhance killing effect of CIK cells on lymphoma cell lines in vitro.
出处 《白血病.淋巴瘤》 CAS 2012年第5期257-260,共4页 Journal of Leukemia & Lymphoma
关键词 淋巴瘤 细胞因子活化的杀伤细胞 来那度胺 Lymphoma Cytokine-induced killer cells Lenalidomide
  • 相关文献

参考文献9

  • 1Schmidt-Wolf RS, Negrin HP, Kiem KG, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Experi Med, 1991, 174:139- 149.
  • 2Li Y, Schmidt-Wolf RS, Wu YF, et al. Optimized protocols for generation of cord blood-derived cytokine-induced killer/natural killer ceils. Anticancer Res, 2010, 30:3493-3499.
  • 3Anderson KC. Lenalidomide and Thalidomide: mechanisms of action- similarities and differences. Semi Hematol, 2005, 42:$3-$8.
  • 4Negrin RS, Leemhuis T, Wells S, et aL A phase ! trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.Biol Blood Marrow Transplan, 2005,11:181-187.
  • 5Olioso P, Giancola R, di Riti M,et al. Immunotherapy with cytokine induced killer cells in solid and hematopoietic turnouts: a pilot clinical trial. Hematol Oncol, 2009, 27:130-139.
  • 6Yang Y, Liu Y, Lu XC, et al. Clinical study of autologous cytokine- induced killer ceils for the treatment of elderly patients with diffuse large B-ceB |ymphoma, Cell Bioehem Biophys, 2012, 62:257-265.
  • 7Lei W ,Mary A, Bartlett JB, et al. Lenalidomide enhnnces natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD~, tumor ceils. Clin Cancer Res, 2008, 14:4651-4657.
  • 8Lin YC, Wang SM, Hui KM, et al. Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays. Experi Hematol, 2005, 33: 671-681.
  • 9Vemeris MR, Kornacker M, Mailander V, et al. Resistance of ex vivo expanded CD~CD;6 T cells to Fas mediated apoptosis. Cancer Immunol Immunother, 2000, 49: 335-345.

同被引文献44

  • 1郭智,谭晓华,高锦,楼金星,刘晓东,何学鹏.CIK治疗耐药性非霍奇金淋巴瘤疗效观察[J].实用癌症杂志,2006,21(1):15-16. 被引量:29
  • 2Schmidt-Wolf IG,Negrin RS,Kiem HP,et al.Use of a SCID mouse/ human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity[J].J Exp Med,1991,174:139-149.
  • 3Linn YC,Lau SK,Liu BH,et al.Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell[J].Immunology,2009,126:423-435.
  • 4Jiang J,Xu N,Wu C,et al.Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells[J].Anticancer Res,2006,26:2237-2242.
  • 5Lu PH,Negrin RS.A novel population of expanded human CD3+ CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J].J Immunol,1994,153:1687-1696.
  • 6Mehta BA,Schmidt-Wolf IG,Weissman IL,et al.Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells[J].Blood,1995,86:3493-3499.
  • 7Olson JA,Leveson-Gower DB,Gill S,et al.NK cells mediate reduction of GVHD by inhibiting activated,alloreactive T cells while retaining GVT effects[J].Blood,2010,115:4293-4301.
  • 8Zoll B,Lefterova P,Ebert O,et al.Modulation of cell surface markers on NK-like T lymphocytes by using IL-2,IL-7 or IL-12 in vitro stimulation[J].Cytokine,2000,12:1385-1390.
  • 9Zoll B,Lefterova P,Csipai M,et al.Generation of cytokine-induced killer cells using exogenous interleukin-2,-7 or-12[J].Cancer Immunol Immunother,1998,47:221-226.
  • 10Lefterova P,Marten A,Buttgereit P,et al.Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicity[J].J Immunother,2000,23:304-310.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部